CERO THERAPEUTICS HOLDINGS, INC. Other General and Administrative Expense
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Other General and Administrative Expense of $843.62 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for the quarter ending 2026-06-30 was $843.62K, a 551.41% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for the quarter ending 2026-03-31 was $1.11M, a 379.86% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for the quarter ending 2025-12-31 was $197.66K.
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for the quarter ending 2025-09-30 was $82.22K, a 72.59% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for fiscal 2025 was $824.71K.
- CERO THERAPEUTICS HOLDINGS, INC. other general and administrative expense for fiscal 2023 was $5.23K.
| Period end | Other General and Administrative Expense 2 month | Other General and Administrative Expense 3 month | Other General and Administrative Expense 5 month | Other General and Administrative Expense 6 month | Other General and Administrative Expense 8 month | Other General and Administrative Expense 9 month | Other General and Administrative Expense 11 month | Other General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $843.62K 10-Q · filed 2026-08-14 | $1.96M 10-Q · filed 2026-08-14 | $2.15M derived: sum of 3 quarters · filed 2026-08-14 | $2.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $1.11M 10-Q · filed 2026-05-15 | $1.31M derived: sum of 2 quarters · filed 2026-05-15 | $1.39M derived: sum of 3 quarters · filed 2026-05-15 | $1.52M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $197.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $279.89K derived: sum of 2 quarters · filed 2026-04-15 | $409.40K derived: sum of 3 quarters · filed 2026-08-14 | $824.71K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $82.22K 10-Q · filed 2025-11-19 | $211.73K derived: sum of 2 quarters · filed 2026-08-14 | $627.04K 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $129.51K 10-Q · filed 2026-08-14 | $361.15K 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | $231.64K 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | $376.76K 10-K · filed 2026-04-15 | |||||||
| 2024-09-30 | $300.00K 10-Q/A · filed 2024-11-20 | $984.37K 10-Q · filed 2025-11-19 | ||||||
| 2024-06-30 | $849.95K 10-Q · filed 2025-08-22 | |||||||
| 2024-03-31 | $0.06 10-Q · filed 2024-05-17 | |||||||
| 2023-12-31 | $5.23K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |